kneat.com, inc. designs, develops, and supplies software for data and document management within regulated environments in the United States and Europe. The company offers Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for modelling regulated data intensive processes for biotechnology, pharmaceutical, and medical device manufacturing industries. kneat.com, inc. was founded in 2006 and is headquartered in Limerick, Ireland.
Industry, Sector and Symbol
Industry Health Information Services
Sub-IndustryN/A
SectorN/A
CIKN/A
PhoneN/A
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesC$1.26 million
Profitability
Miscellaneous
Employees60
Next Earnings Date8/27/2019 (Estimated)
OptionableNot Optionable
Kneat.com (CVE:KSI) Frequently Asked Questions
What is Kneat.com's stock symbol?
Kneat.com trades on the Canadian Venture Exchange (CVE) under the ticker symbol "KSI."
How were Kneat.com's earnings last quarter?
Kneat.com Inc (CVE:KSI) issued its earnings results on Tuesday, May, 28th. The company reported ($0.04) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.03) by $0.01. The firm earned $0.41 million during the quarter, compared to the consensus estimate of $0.44 million. View Kneat.com's Earnings History.
When is Kneat.com's next earnings date?
What is the consensus analysts' recommendation for Kneat.com?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Kneat.com in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Kneat.com.
Has Kneat.com been receiving favorable news coverage?
Media stories about KSI stock have trended negative recently, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Kneat.com earned a news impact score of -2.3 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Kneat.com.
Who are some of Kneat.com's key competitors?
Some companies that are related to Kneat.com include Sensyne Health (SENS), Alcidion Group (ALC), Mach7 Technologies (M7T), Medadvisor (MDR), Induction Healthcare Group (INHC), Reliq Health Technologies (RHT), Vitalhub (VHI), CogState (CGS), 1ST Group (1ST), Oneview Healthcare (ONE), Diagnos (ADK), ICSGlobal (ICS), Jayex Healthcare (JHL), CardioComm Solutions (EKG) and Global Health (GLH).
What other stocks do shareholders of Kneat.com own?
Who are Kneat.com's key executives?
Kneat.com's management team includes the folowing people:
- Mr. Edmund Ryan, Co-Founder, CEO, Pres, Sales Director & Exec. Director (Age 55)
- Mr. Brian Ahearne, Co-Founder, Quality Director & Company Sec. (Age 50)
- Mr. Kevin Fitzgerald, Co-Founder, Director of R&D and Exec. Director (Age 49)
- Ms. Sarah Lynn Oliver, Chief Financial Officer (Age 34)
How do I buy shares of Kneat.com?
Shares of KSI and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Kneat.com's stock price today?
One share of KSI stock can currently be purchased for approximately C$1.25.
How big of a company is Kneat.com?
What is Kneat.com's official website?
MarketBeat Community Rating for Kneat.com (CVE KSI)
MarketBeat's community ratings are surveys of what our community members think about Kneat.com and other stocks. Vote "Outperform" if you believe KSI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KSI will underperform the S&P 500 over the long term. You may vote once every thirty days.
